FAS Wealth Partners’s Merck MRK Stock Holding History

FAS Wealth Partners’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.56M	Buy	43,241 +2,514	+6%	+$294K	0.29%	74
2026 Q1	$4.9M	Buy	40,727 +1,276	+3%	+$147K	0.31%	71
2025 Q4	$4.15M	Buy	39,451 +2,522	+7%	+$237K	0.27%	79
2025 Q3	$3.1M	Buy	36,929 +1,087	+3%	+$89.5K	0.21%	95
2025 Q2	$2.84M	Buy	35,842 +244	+0.7%	+$19.4K	0.21%	99
2025 Q1	$3.2M	Buy	35,598 +764	+2%	+$71.3K	0.26%	86
2024 Q4	$3.47M	Buy	34,834 +713	+2%	+$73.5K	0.29%	75
2024 Q3	$3.87M	Buy	34,121 +1,359	+4%	+$161K	0.31%	73
2024 Q2	$4.06M	Buy	32,762 +697	+2%	+$89.8K	0.35%	64
2024 Q1	$4.23M	Buy	32,065 +956	+3%	+$118K	0.37%	60
2023 Q4	$3.39M	Buy	31,109 +2,839	+10%	+$295K	0.32%	70
2023 Q3	$2.91M	Buy	28,270 +132	+0.5%	+$14.2K	0.31%	72
2023 Q2	$3.25M	Buy	28,138 +1,973	+8%	+$224K	0.41%	54
2023 Q1	$2.78M	Sell	26,165 -3,692	-12%	-$399K	0.3%	72
2022 Q4	$3.31M	Buy	29,857 +2,830	+10%	+$289K	0.38%	59
2022 Q3	$2.33M	Buy	27,027 +4,051	+18%	+$362K	0.26%	63
2022 Q2	$2.1M	Buy	22,976 +4,122	+22%	+$365K	0.22%	78
2022 Q1	$1.55M	Buy	18,854 +3,376	+22%	+$266K	0.15%	99
2021 Q4	$1.19M	Sell	15,478 -400	-3%	-$31.9K	0.11%	119
2021 Q3	$1.19M	Buy	15,878 +1,352	+9%	+$103K	0.11%	114
2021 Q2	$1.13M	Buy	14,526 +1,228	+9%	+$91.3K	0.11%	121
2021 Q1	$978K	Sell	13,298 -199	-1%	-$14.7K	0.1%	125
2020 Q4	$1.05M	Buy	13,497 +118	+0.9%	+$9.03K	0.12%	109
2020 Q3	$1.06M	Buy	13,379 +61	+0.5%	+$4.78K	0.14%	105
2020 Q2	$983K	Buy	13,318 +80	+0.6%	+$6.02K	0.14%	105
2020 Q1	$972K	Buy	13,238 +112	+0.9%	+$8.8K	0.17%	98
2019 Q4	$1.14M	Buy	13,126 +455	+4%	+$37.4K	0.19%	81
2019 Q3	$1.02M	Sell	12,671 -38	-0.3%	-$3.04K	0.18%	86
2019 Q2	$1.02M	Buy	12,709 +12	+0.1%	+$919	0.19%	84
2019 Q1	$1.01M	Buy	12,697 +115	+0.9%	+$8.6K	0.2%	81
2018 Q4	$917K	Sell	12,582 -687	-5%	-$48.5K	0.21%	78
2018 Q3	$898K	Buy	13,269 +54	+0.4%	+$3.44K	0.2%	72
2018 Q2	$765K	Buy	13,215 +61	+0.5%	+$3.44K	0.21%	76
2018 Q1	$684K	Sell	13,154 -1,023	-7%	-$55.3K	0.2%	79
2017 Q4	$761K	Buy	14,177 +232	+2%	+$12.9K	0.2%	77
2017 Q3	$852K	Buy	13,945 +883	+7%	+$53.5K	0.24%	70
2017 Q2	$799K	Buy	13,062 +30	+0.2%	+$1.83K	0.24%	70
2017 Q1	$790K	Sell	13,032 -1,129	-8%	-$68.5K	0.24%	69
2016 Q4	$795K	Buy	14,161 +1,183	+9%	+$69.2K	0.24%	56
2016 Q3	$773K	Buy	12,978 +1,088	+9%	+$63.6K	0.25%	55
2016 Q2	$654K	Buy	11,890 +1,092	+10%	+$58.1K	0.24%	55
2016 Q1	$545K	Buy	10,798 +1,087	+11%	+$53.2K	0.28%	46
2015 Q4	$489K	Buy	9,711 +37	+0.4%	+$1.86K	0.24%	61
2015 Q3	$456K	Buy	9,674 +489	+5%	+$26K	0.26%	50
2015 Q2	$499K	Buy	9,185 +5	+0.1%	+$280	0.25%	47
2015 Q1	$504K	Buy	9,180 +4	+0%	+$226	0.26%	40
2014 Q4	$497K	Buy	9,176 +4	+0%	+$223	0.26%	41
2014 Q3	$519K	Sell	9,172 -310	-3%	-$17.4K	0.3%	31
2014 Q2	$523K	Buy	9,482 +404	+4%	+$22K	0.3%	29
2014 Q1	$492K	Buy	9,078 +23	+0.3%	+$1.19K	0.33%	27
2013 Q4	$432K	Buy	+9,055	New	+$414K	0.26%	34

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

FAS Wealth Partners's MRK Position: Q2 2026 in Review

FAS Wealth Partners increased its Merck (MRK) stake by 6.2% in Q2 2026, buying an estimated $294K and bringing the position to 43,241 shares worth $5.56M. The position accounts for 0.29% of the portfolio, ranked #74.

FAS Wealth Partners first reported a position in MRK in Q4 2013 and has held it in 51 quarters since. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

FAS Wealth Partners held 43,241 shares of Merck worth $5.56M as of Q2 2026.
FAS Wealth Partners bought 2,514 Merck shares in Q2 2026, an estimated $294K.
Merck made up 0.29% of FAS Wealth Partners's portfolio in Q2 2026, its #74 holding.
FAS Wealth Partners first reported a position in Merck in Q4 2013 and has held it in 51 quarters since.
1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on FAS Wealth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.